Roose J, Huls G, van Beest M, Moerer P, van der Horn K, Goldschmeding R, Logtenberg T, Clevers H
Department of Immunology and Center for Biomedical Genetics, Department of Pathology, University Medical Center Utrecht, Post Office Box 85500, 3508 GA Utrecht, Netherlands.
Science. 1999 Sep 17;285(5435):1923-6. doi: 10.1126/science.285.5435.1923.
Mutations in APC or beta-catenin inappropriately activate the transcription factor Tcf4, thereby transforming intestinal epithelial cells. Here it is shown that one of the target genes of Tcf4 in epithelial cells is Tcf1. The most abundant Tcf1 isoforms lack a beta-catenin interaction domain. Tcf1(-/-) mice develop adenomas in the gut and mammary glands. Introduction of a mutant APC allele into these mice substantially increases the number of these adenomas. Tcf1 may act as a feedback repressor of beta-catenin-Tcf4 target genes and thus may cooperate with APC to suppress malignant transformation of epithelial cells.
APC或β-连环蛋白中的突变会不适当地激活转录因子Tcf4,从而使肠上皮细胞发生转化。本文表明,上皮细胞中Tcf4的靶基因之一是Tcf1。最丰富的Tcf1亚型缺乏β-连环蛋白相互作用结构域。Tcf1基因敲除小鼠在肠道和乳腺中会发生腺瘤。将突变的APC等位基因导入这些小鼠体内会显著增加这些腺瘤的数量。Tcf1可能作为β-连环蛋白-Tcf4靶基因的反馈抑制因子,因此可能与APC协同作用以抑制上皮细胞的恶性转化。